ADCK2 mRNA overexpression in NSCLC was associated with poor overall survival (OS) (P = 0.00093) and poor progression-free survival (PPS, P =0.0061) (Figure 1C-D). This evidence concerns the gene ADCK2 and non-small cell lung carcinoma.